Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe)
Clinical trial NCT00630929 · COMPLETED
Trial details
- NCT number
- NCT00630929
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.